The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia

Trends in Pharmacological Sciences

Volumn 26, Issue 9, 2005, Pages 477-484

  Neale, Joseph H ^a   Olszewski, Rafal T ^a   Gehl, Laura M ^a   Wroblewska, Barbara ^a   Bzdega, Tomasz ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 MERCAPTOPROPYL)PENTANEDIOIC ACID; 2 (PHOSPHONOMETHYL)PENTANOIC ACID; 2 [(PENTAFLUOROPHENYLMETHYL)HYDROXYPHOSPHINYL]METHYLPENTANEDIOIC ACID; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINOPYRROLIDIN 2,4 DICARBOXYLATE; CLOZAPINE; CYCLOSERINE; EGLUMETAD; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR; GPI 5232; LAMOTRIGINE; METABOTROPIC RECEPTOR AGONIST; N [N (1,3 DICARBOXYPROPYL)CARBAMOYL]LEUCINE; N [N (1,3 DICARBOXYPROPYL)CARBAMOYL]METHIONINE; N [N (1,3 DICARBOXYPROPYL)CARBAMOYL]TYROSINE; N ACETYLASPARTYLGLUTAMIC ACID; PHENCYCLIDINE; RISPERIDONE; UNCLASSIFIED DRUG; ZJ 11; ZJ 17; ZJ 43;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MODEL; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; DIABETIC NEUROPATHY; ENZYME INHIBITION; EXCITOTOXICITY; INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; STROKE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN ISCHEMIA; DIABETIC NEUROPATHIES; DIPEPTIDES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; PAIN; PROTEASE INHIBITORS; SCHIZOPHRENIA;

EID: 23944474406     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.07.004     Document Type: Review

References (68)

1. A. Curatolo Brain concentration of glutamic, aspartic, N-acetylaspartic and N-acetylaspartyl-glutamic acids in rats chronically treated with aspartic and N-acetylaspartic acids Boll. Soc. Ital. Biol. Sper. 41 1965 588 590
2. E. Miyamoto Identification of N-acetyl-alpha-aspartylglutamic acid in the bovine brain J. Neurochem. 13 1966 999 1003
3. J.H. Neale N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system J. Neurochem. 75 2000 443 452
4. J.T. Coyle The nagging question of the function of N- acetylaspartylglutamate Neurobiol. Dis. 4 1997 231 238
5. B. Wroblewska N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells J. Neurochem. 69 1997 174 181
6. C. Schweitzer Characterization of [3H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors Neuropharmacology 39 2000 1700 1706
7. B. Wroblewska N-acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells J. Neurochem. 61 1993 943 948
8. B. Wroblewska N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes Glia 24 1998 172 179
9. S. Ghose N-acetylaspartylglutamate stimulates metabotropic glutamate receptor 3 to regulate expression of the GABA(A) alpha6 subunit in cerebellar granule cells J. Neurochem. 69 1997 2326 2335
10. V. Bruno Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells Neuroscience 85 1998 751 757
11. J. Zhao NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance Eur. J. Neurosci. 13 2001 340 346
12. E.R. Garrido-Sanabria GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism J. Neurophysiol. 91 2004 182 193
13. R.E. Carter Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase Proc. Natl. Acad. Sci. U. S. A. 93 1996 749 753
14. T. Bzdega Molecular cloning of a peptidase against N- acetylaspartylglutamate from a rat hippocampal cDNA library J. Neurochem. 69 1997 2270 2277
15. R. Luthi-Carter Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II Proc. Natl. Acad. Sci. U. S. A. 95 1998 3215 3220
16. T. Bzdega The cloning and characterization of a second brain enzyme with NAAG peptidase activity J. Neurochem. 89 2004 627 635
17. D.J. Bacich Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate J. Neurochem. 83 2002 20 29
18. Bacich, D.J. et al. Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury. J. Neurochem. (in press)
19. J. Bischofberger, and D. Schild Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptor J. Neurophysiol. 76 1996 2089 2092
20. P.F. Jackson Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase J. Med. Chem. 39 1996 619 622
21. P.F. Jackson, and B.S. Slusher Design of NAALADase inhibitors: a novel neuroprotective strategy Curr. Med. Chem. 8 2001 949 957
22. A.P. Kozikowski Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase) J. Med. Chem. 44 2001 298 301
23. A.P. Kozikowski Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents J. Med. Chem. 47 2004 1729 1738
24. E.A. Waxman, and D.R. Lynch N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease Neuroscientist 11 2005 37 49
25. X.M. Lu N-acetylaspartylglutamate protects against transient focal cerebral ischemia in rats Eur. J. Pharmacol. 408 2000 233 239
26. F.C. Tortella Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons Eur. J. Pharmacol. 402 2000 31 37
27. B.S. Slusher Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury Nat. Med. 5 1999 1396 1402
28. A.J. Williams Electroencephalogram analysis and neuroprotective profile of the N-Acetylated-alpha-Linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats J. Pharmacol. Exp. Ther. 299 2001 48 57
29. R.N. Weinreb, and L.A. Levin Is neuroprotection a viable therapy for glaucoma? Arch. Ophthalmol. 117 1999 1540 1544
30. C. Harada N-acetylated-alpha-linked-acidic dipeptidase inhibitor has a neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia Neurosci. Lett. 292 2000 134 136
31. Z. Cai Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia Eur. J. Pharmacol. 437 2002 139 145
32. A.A. Sima, and K. Sugimoto Experimental diabetic neuropathy: an update Diabetologia 42 1999 773 788
33. W. Zhang GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats J. Neurol. Sci. 194 2002 21 28
34. A. Berent-Spillson Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3 J. Neurochem. 89 2004 90 99
35. A.G. Thomas Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta Eur. J. Pharmacol. 430 2001 33 40
36. C. Zhong NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats J. Neurotrauma 22 2005 266 276
37. S.M. Carlton Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat Neuroscience 105 2001 957 969
38. D. Julius, and A.I. Basbaum Molecular mechanisms of nociception Nature 413 2001 203 210
39. V. Neugebauer Metabotropic glutamate receptors-important modulators of nociception and pain behavior Pain 98 2002 1 8
40. E.F. Sharpe Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo Br. J. Pharmacol. 135 2002 1255 1262
41. th Peripheral Group II metabotropic glutamate receptors (mGluR2/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception J. Neurosci. 22 2002 6388 6393
42. th Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation Pain 106 2003 411 417
43. J.R. Moffett Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain J. Histochem. Cytochem. 41 1993 559 570
44. C.B. Cangro Immunohistochemistry and biosynthesis of N- acetylaspartylglutamate in spinal sensory ganglia J. Neurochem. 49 1987 1579 1588
45. T. Yamamoto Spinal N-acetyl-[alpha]-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat Brain Res. 909 2001 138 144
46. T. Yamamoto Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test Neuroscience 102 2001 473 479
47. S-R. Chen Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain J. Pharmacol. Exp. Ther. 300 2002 662 667
48. T. Yamamoto Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model Eur. J. Neurosci. 20 2004 483 494
49. J.D. Rothstein Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials Ann. Neurol. 53 2003 423 426
50. M.J. Strong Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy Expert Opin. Investig. Drugs 13 2004 1593 1614
51. G.D. Ghadge Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Proc. Natl. Acad. Sci. U. S. A. 100 2003 9554 9559
52. G. Tsai, and J.T. Coyle Glutamatergic mechanisms in schizophrenia Annu. Rev. Pharmacol. Toxicol. 42 2002 165 179
53. D.C. Javitt, and J.T. Coyle Decoding schizophrenia Sci. Am. 290 2004 48 55
54. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
55. J.H. Krystal Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia Arch. Gen. Psychiatry 59 2002 663 664
56. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
57. J. Cartmell The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats J. Pharmacol. Exp. Ther. 291 1999 161 170
58. R.T. Olszewski NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR J. Neurochem. 89 2004 876 885
59. J.H. Krystal Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects Psychopharmacology (Berl.) 179 2005 303 309
60. G. Gegelashvili The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms Neurochem. Int. 37 2000 163 170
61. E. Aronica Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins Eur. J. Neurosci. 17 2003 2106 2118
62. H.M. Valivullah Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites J. Neurochem. 63 1994 1714 1719
63. G.L. Westbrook High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture J. Neurosci. 6 1986 3385 3392
64. M.L. Koenig N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro NeuroReport 5 1994 1063 1068
65. M. D'Onofrio Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways J. Neurochem. 78 2001 435 445
66. G. Losi NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons Neuropharmacology 46 2004 490 496
67. R. Bergeron NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons Neuropsychopharmacology 30 2005 7 16
68. F. Miskevich Interaction between metabotropic and NMDA subtypes of glutamate receptors in sprout suppression at young synapses J. Neurosci. 22 2002 226 238